immune system
• increased number of Cd27+ Cd11b- cells in spleen and bone marrow
• reduced number of Cd27- Cd11b+ cells in spleen and bone marrow
• increased Tnfa expression in splenocytes in vitro after stimulation with Il18, Il18 + Il2, or lipopolysaccharide and subsequent treatment with PMA and ionomycin
• decreased Ifng expression in splenocytes in vitro after stimulation with Il18, Il18 + Il2, or lipopolysaccharide and subsequent treatment with PMA and ionomycin
• number of Cd27+ Cd11b+ and Cd27- Cd11b- cells in spleen
|
• increased number of Cd27+ Cd11b- cells in spleen and bone marrow
|
• in spleen
|
• in spleen
|
• reduced number of Cd27- Cd11b+ cells in spleen and bone marrow
|
• after stimulation with lipopolysaccharide
|
• decreased Ifng expression in splenocytes in vitro after stimulation with Il18, Il18 + Il2, or lipopolysaccharide and subsequent treatment with PMA and ionomycin
|
hematopoietic system
• increased number of Cd27+ Cd11b- cells in spleen and bone marrow
• reduced number of Cd27- Cd11b+ cells in spleen and bone marrow
• increased Tnfa expression in splenocytes in vitro after stimulation with Il18, Il18 + Il2, or lipopolysaccharide and subsequent treatment with PMA and ionomycin
• decreased Ifng expression in splenocytes in vitro after stimulation with Il18, Il18 + Il2, or lipopolysaccharide and subsequent treatment with PMA and ionomycin
• number of Cd27+ Cd11b+ and Cd27- Cd11b- cells in spleen
|
• increased number of Cd27+ Cd11b- cells in spleen and bone marrow
|
• in spleen
|
• in spleen
|
• reduced number of Cd27- Cd11b+ cells in spleen and bone marrow
|
homeostasis/metabolism
• after stimulation with lipopolysaccharide
|
growth/size/body
N |
• weight gain during first 24 weeks
|